HT
DNA icon

Headlands Technologies’s Ginkgo Bioworks DNA Stock Holding History

Headlands Technologies’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-38,712
Closed -$322K – 781
2025
Q4 		$322K Sell
38,712
-2,284
-6% -$24.6K 0.03% 500
2025
Q3 		$598K Buy
40,996
+178
+0.4% +$2.13K 0.05% 322
2025
Q2 		$459K Buy
40,818
+9,408
+30% +$72.9K 0.06% 317
2025
Q1 		$179K Buy
31,410
+13,785
+78% +$140K 0.02% 475
2024
Q4 		$173K Buy
+17,625
New +$151K 0.02% 556
2024
Q3 		– Hold
0
– -$6 – 1267
2024
Q2 		– Sell
-698
Closed -$20.8K – 1099
2024
Q1 		$32.4K Sell
698
-2,590
-79% -$134K 0.01% 808
2023
Q4 		$222K Buy
3,288
+2,557
+350% +$157K 0.07% 255
2023
Q3 		$53K Buy
+731
New +$58.4K 0.03% 432
2023
Q2 		– Sell
-45
Closed -$2.41K – 829
2023
Q1 		$2.41K Buy
+45
New +$2.85K ﹤0.01% 414

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Headlands Technologies's DNA Position: Q1 2026 in Review

Headlands Technologies sold out of Ginkgo Bioworks (DNA) in Q1 2026, closing a stake of 38,712 shares — an estimated $322K sold.

Headlands Technologies first reported a position in DNA in Q1 2023 and held it in 9 quarters. The position peaked at $598K in Q3 2025. 175 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Headlands Technologies reported no remaining Ginkgo Bioworks position as of Q1 2026 after selling out during the quarter.
  • Headlands Technologies sold 38,712 Ginkgo Bioworks shares in Q1 2026, an estimated $322K.
  • Headlands Technologies first reported a position in Ginkgo Bioworks in Q1 2023 and held it in 9 quarters.
  • Headlands Technologies's Ginkgo Bioworks position peaked at $598K in Q3 2025.
  • 175 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Headlands Technologies's 13F filing for Q1 2026, filed 13 May 2026.